Company / Revenue per Share
Valion Bio, Inc. Revenue per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$13.64
FY2024
5-year range
$0.13 / $19.01
FY2022-FY2024
Trend
-28.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.13 to $13.64 over the past 2 years.
Based on SEC 10-K filings.
13.64 in FY2024.
Improved from $0.13 to $13.64 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, revenue per share decreased 28.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $13.64 | -28.3% |
| FY2023 | $19.01 | +14594.6% |
| FY2022 | $0.13 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026